Skip to content

Livestrong Cancer Institutes' Patient Reported Outcomes Study

Livestrong Cancer Institutes' Patient Reported Outcomes Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04627077
Acronym
LCI PROs
Enrollment
121
Registered
2020-11-13
Start date
2018-01-22
Completion date
2019-01-25
Last updated
2020-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Therapy, Neoplasms

Brief summary

The goal of this study will be to collect baseline patient reported outcome measures at the Livestrong Cancer Institutes (LCI) with the goal of improving quality care and to inform decision making by patients, providers, and researchers for future LCI initiatives.

Detailed description

This proposed study is a descriptive study of the adult oncology population at the Seton Infusion Center in order to provide information about patient needs and identify areas for further research and resource allocation. The patient reported outcome measures being collected cover the following domains: anxiety, depression, fatigue, physical function, financial toxicity and pain. Patients and caregivers will be informed about the study and given the opportunity to enroll at the time of routine clinic visits at the Dell Seton Medical Center at The University of Texas Seton Infusion Center (SIC). Patients choosing to enroll in the study will be provided informed consent, and then allowed to complete the measures during their clinic visit on an iPad provided by the research staff. After IRB approval for a period of 1-2 months data collection will take place at the SIC clinic at DMS. Upon completion of the measures patients will be asked for an email address and phone number so that a follow up link to survey questions can be sent to them in 3 months.

Interventions

None listed

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient aged 18 years and older, being treated for cancer at the Seton Infusion Clinic * Patient cognitively and physically able to complete questionnaires on an ipad in English or Spanish.

Exclusion criteria

* -Patient unable to speak English or Spanish as required for study data collection * Patient cognitively or physically unable to complete measures

Design outcomes

Primary

MeasureTime frameDescription
Change in Anxiety - PROMISBaseline and 3 month follow upPROMIS adaptive anxiety
Change in Depression - PROMISBaseline and 3 month follow upPROMIS adaptive Depression
Change in Pain - PROMISBaseline and 3 month follow upPROMIS adaptive pain
Change in Physical Function- PROMISBaseline and 3 month follow upPROMIS adaptive physical function
Change in Fatigue - PROMISBaseline and 3 month follow upPROMIS adaptive fatigue
Change in Financial ToxicityBaseline and 3 month follow upComprehensive Score for financial Toxicity (COST) questionnaire
Change in Patient satisfaction with careBaseline and 3 month follow upThe CAHPS® Cancer Care Survey
Change in Quality of Life - FACT-GBaselineFunctional Assessment of Cancer Therapy (FACT-G)

Secondary

MeasureTime frameDescription
Change in Impact on CaregiversBaseline and 3 month follow upBrief Assessment Scale for Caregivers (BASC), range -27 to 12, higher scores poorer outcomes

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026